Search | IOVS | ARVO Journals

Showing 1 – 20 of 36

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Factors associated with visual outcome after anti-vascular endothelial growth factor therapy in myopic choroidal neovascularization

Sakiko Minami; Atsuro Uchida; Yasuaki Mushiga; Norihiro Nagai; Misa Suzuki; Kazuhiro Watanabe; Hideki Sonobe; Toshihide Kurihara; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1082. doi:

ARVO Annual Meeting Abstract July 2019

Detection of slight changes in the visual function using EvokeDx ® system in healthy adults

Sakiko Minami; Norihiro Nagai; Misa Suzuki; Toshihide Kurihara; Mamoru Kamoshita; Hideki Sonobe; Kazuhiro Watanabe; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2494. doi:

ARVO Annual Meeting Abstract July 2019

Internal limiting membrane peeling may cause post-operative visual field defects in epiretinal membrane patients

Tomoki Kurihara; Kazuhiro Watanabe; Hideki Sonobe; Toshihide Kurihara; Norihiro Nagai; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5780. doi:

ARVO Annual Meeting Abstract July 2018

Predictive factors for better short-term outcome in idiopathic epiretinal membrane after pars plana vitrectomy

Sakiko Minami; Yuta Shigeno; Hajime Shinoda; Norihiro Nagai; Toshihide Kurihara; Mamoru Kamoshita; Kazuhiro Watanabe; Hideki Sonobe; Yuki Hidaka; Kazuo Tsubota; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):862. doi:

ARVO Annual Meeting Abstract June 2017

Reflectivity of the retinal cystoid space and visual outcome after intravitreal ranibizmab injection in diabetic macular edema

Norihiro Nagai; Misa Suzuki; Toshihide Kurihara; Mamoru Kamoshita; Hideki Sonobe; Sakiko Minami; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1902. doi:

ARVO Annual Meeting Abstract September 2016

Predictive factors for non-response to intravitreal aflibercept treatment in neovascular age-related macular degeneration

Norihiro Nagai; Misa Suzuki; Atsuro Uchida; Toshihide Kurihara; Mamoru Kamoshita; Sakiko Minami; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3689. doi:

ARVO Annual Meeting Abstract September 2016

Treatment Responses to the Intravitreal Aflibercept in Polypoidal Choroidal Vasculopathy at 1 year

Sakiko Minami; Norihiro Nagai; Misa Suzuki; Toshihide Kurihara; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2650. doi:

ARVO Annual Meeting Abstract September 2016

Aerobic exercise protects retinal function in type 2 diabetic mice

Mamoru Kamoshita; Hideto Osada; Eriko Toda; Kokoro Sano; Motoko Kawashima; Norihiro Nagai; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3206. doi:

Clinical and Epidemiologic Research March 2014

Association of Serum Lipids With Macular Thickness and Volume in Type 2 Diabetes Without Diabetic Macular Edema

PDF

Mariko Sasaki; Motoko Kawashima; Ryo Kawasaki; Atsuro Uchida; Takashi Koto; Hajime Shinoda; Kazuo Tsubota; Jie Jin Wang; Yoko Ozawa
TAGS: diabetes mellitus, diabetes mellitus, type 2, lipids, macular edema, diabetic, volume, ldl cholesterol lipoproteins, risk factors, hemoglobin a, glycosylated
Invest. Ophthalmol. Vis. Sci.. 2014; 55(3):1749-1753. doi: https://doi.org/10.1167/iovs.13-13035

ARVO Annual Meeting Abstract June 2013

Baseline characteristics and response to intravitreal ranibizumab therapy for age-related macular degeneration

Misa Suzuki; Norihiro Nagai; Kanako Izumi-Nagai; Hajime Shinoda; Takashi Koto; Atsuro Uchida; HIroshi Mochimaru; Kenya Yuki; Kazuo Tsubota; Yoko Ozawa; Laboratory of Retinal Cell Biology,Keio University Center for Integrated Medical Research

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4093. doi:

ARVO Annual Meeting Abstract June 2013

Associations of Serum Lipids with Macular Morphology in Patients without Diabetic Macular Edema

Mariko Sasaki; Motoko Kawashima; Ryo Kawasaki; Miho Kawai; Atsuro Uchida; Takashi Koto; Hajime Shinoda; Kazuo Tsubota; Jie Wang; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1237. doi:

ARVO Annual Meeting Abstract March 2012

Associations Between Early Signs Of Age-related Macular Degeneration (AMD) And Risk Of AMD In The Fellow Eye In Patients With Unilateral AMD

Mariko Sasaki; Ryo Kawasaki; Asturo Uchida; Takashi Koto; Hiroshi Mochimaru; Hajime Shinoda; Tien Y. Wong; Kazuo Tsubota; Yoko Ozawa

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6511. doi:

Retinal Cell Biology October 2007

Suppression of Choroidal Neovascularization by Dendritic Cell Vaccination Targeting VEGFR2

PDF

Hiroshi Mochimaru; Norihiro Nagai; Go Hasegawa; Chie Kudo-Saito; Tomonori Yaguchi; Yoshihiko Usui; Toshihide Kurihara; Takashi Koto; Shingo Satofuka; Hajime Shinoda; Yoko Ozawa; Kazuo Tsubota; Yutaka Kawakami; Susumu Ishida
TAGS: choroidal neovascularization, peptides, vaccination, dendritic cell vaccine, mice, t-lymphocytes
Invest. Ophthalmol. Vis. Sci.. 2007; 48(10):4795-4801. doi: https://doi.org/10.1167/iovs.07-0425

Retinal Cell Biology September 2007

Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice

PDF

Takashi Koto; Norihiro Nagai; Hiroshi Mochimaru; Toshihide Kurihara; Kanako Izumi-Nagai; Shingo Satofuka; Hajime Shinoda; Kousuke Noda; Yoko Ozawa; Makoto Inoue; Kazuo Tsubota; Yuichi Oike; Susumu Ishida
TAGS: anti-inflammatory agents, choroidal neovascularization, mice, eicosapentaenoic acid, peroxisome proliferator-activated receptors, choroid, molecule
Invest. Ophthalmol. Vis. Sci.. 2007; 48(9):4328-4334. doi: https://doi.org/10.1167/iovs.06-1148

ARVO Annual Meeting Abstract May 2007

Anti-Inflammatory Effect of Eicosapentaenoic Acid on Diabetic Retina in vivo and Cytokine Expression in vitro

T. Koto; N. Nagai; H. Mochimaru; K. Izumi-Nagai; S. Satofuka; H. Shinoda; T. Kurihara; Y. Ozawa; K. Tsubota; S. Ishida

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1360. doi:

ARVO Annual Meeting Abstract May 2007

Suppression of Choroidal Neovascularization by Inhibiting Angiotensin-Converting Enzyme: Minimal Role of Bradykinin

N. Nagai; Y. Oike; K. Izumi-Nagai; T. Koto; S. Satofuka; H. Shinoda; Y. Ozawa; M. Inoue; K. Tsubota; S. Ishida

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1467. doi:

ARVO Annual Meeting Abstract May 2007

Nonproteolytically Activated Prorenin Promotes Pathologic, but Not Physiologic, Retinal Neovascularization

S. Satofuka; A. Ichihara; N. Nagai; T. Koto; H. Shinoda; Y. Ozawa; K. Tsubota; H. Itoh; Y. Oike; S. Ishida

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4055. doi:

Retinal Cell Biology May 2007

Suppression of Choroidal Neovascularization by Inhibiting Angiotensin-Converting Enzyme: Minimal Role of Bradykinin

PDF

Norihiro Nagai; Yuichi Oike; Kanako Izumi-Nagai; Takashi Koto; Shingo Satofuka; Hajime Shinoda; Kousuke Noda; Yoko Ozawa; Makoto Inoue; Kazuo Tsubota; Susumu Ishida
TAGS: choroidal neovascularization, angiotensin-converting enzyme, bradykinin, vascular endothelial growth factor a, intercellular adhesion molecule 1, monocyte chemoattractant protein-1
Invest. Ophthalmol. Vis. Sci.. 2007; 48(5):2321-2326. doi: https://doi.org/10.1167/iovs.06-1296

Retinal Cell Biology January 2007

Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization

PDF

Shingo Satofuka; Atsuhiro Ichihara; Norihiro Nagai; Takashi Koto; Hajime Shinoda; Kousuke Noda; Yoko Ozawa; Makoto Inoue; Kazuo Tsubota; Hiroshi Itoh; Yuichi Oike; Susumu Ishida
TAGS: intercellular adhesion molecule 1, ischemia, retinal diseases, retinal neovascularization, vascular endothelial growth factor a, vascular endothelial growth factor receptor-2, vegfr-1, mice, proteins
Invest. Ophthalmol. Vis. Sci.. 2007; 48(1):422-429. doi: https://doi.org/10.1167/iovs.06-0534

Retinal Cell Biology June 2006

Suppression of Ocular Inflammation in Endotoxin-Induced Uveitis by Inhibiting Nonproteolytic Activation of Prorenin

PDF

Shingo Satofuka; Atsuhiro Ichihara; Norihiro Nagai; Kenji Yamashiro; Takashi Koto; Hajime Shinoda; Kousuke Noda; Yoko Ozawa; Makoto Inoue; Kazuo Tsubota; Fumiaki Suzuki; Yuichi Oike; Susumu Ishida
TAGS: endotoxins, eye inflammation, intercellular adhesion molecule 1, interleukin-6, leukocytes, monocyte chemoattractant protein-1, proteins, uveitis, leukocyte cell adhesion
Invest. Ophthalmol. Vis. Sci.. 2006; 47(6):2686-2692. doi: https://doi.org/10.1167/iovs.05-1458

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Factors associated with visual outcome after anti-vascular endothelial growth factor therapy in myopic choroidal neovascularization

Detection of slight changes in the visual function using EvokeDx ® system in healthy adults

Internal limiting membrane peeling may cause post-operative visual field defects in epiretinal membrane patients

Predictive factors for better short-term outcome in idiopathic epiretinal membrane after pars plana vitrectomy

Reflectivity of the retinal cystoid space and visual outcome after intravitreal ranibizmab injection in diabetic macular edema

Predictive factors for non-response to intravitreal aflibercept treatment in neovascular age-related macular degeneration

Treatment Responses to the Intravitreal Aflibercept in Polypoidal Choroidal Vasculopathy at 1 year

Aerobic exercise protects retinal function in type 2 diabetic mice

Association of Serum Lipids With Macular Thickness and Volume in Type 2 Diabetes Without Diabetic Macular Edema

Baseline characteristics and response to intravitreal ranibizumab therapy for age-related macular degeneration

Associations of Serum Lipids with Macular Morphology in Patients without Diabetic Macular Edema

Associations Between Early Signs Of Age-related Macular Degeneration (AMD) And Risk Of AMD In The Fellow Eye In Patients With Unilateral AMD

Suppression of Choroidal Neovascularization by Dendritic Cell Vaccination Targeting VEGFR2

Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice

Anti-Inflammatory Effect of Eicosapentaenoic Acid on Diabetic Retina in vivo and Cytokine Expression in vitro

Suppression of Choroidal Neovascularization by Inhibiting Angiotensin-Converting Enzyme: Minimal Role of Bradykinin

Nonproteolytically Activated Prorenin Promotes Pathologic, but Not Physiologic, Retinal Neovascularization

Suppression of Choroidal Neovascularization by Inhibiting Angiotensin-Converting Enzyme: Minimal Role of Bradykinin

Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization

Suppression of Ocular Inflammation in Endotoxin-Induced Uveitis by Inhibiting Nonproteolytic Activation of Prorenin

To View More...

You must be signed into an individual account to use this feature.